Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. ir. Wim Van Criekinge

Faculty of Bioscience Engineering > Department of Data analysis and mathematical modelling

Work address: Coupure Links 653, geb. A
9000 Gent
Email: Wim.VanCriekinge@UGent.be
ORCID iD: 0000-0003-2971-5539

Show Sort by

Add to list
- Journal Article
- open access
Underestimated effect of intragenic HIV-1 DNA methylation on viral transcription in infected individuals.

Sam Kint (UGent) , Wim Trypsteen (UGent) , Ward De Spiegelaere (UGent) , Eva Malatinková (UGent) , S Kinloch-de Loes, Tim De Meyer (UGent) , Wim Van Criekinge (UGent) and Linos Vandekerckhove (UGent)

(2020) Clin Epigenetics. 12(1).
Add to list
MGMT promoter methylation cutoff with safety margin for selecting glioblastoma patients into trials omitting temozolomide : a pooled analysis of four clinical trials

Monika E Hegi, Els Genbrugge, Thierry Gorlia, Roger Stupp, Mark R Gilbert, Olivier L Chinot, L Burt Nabors, Greg Jones, Wim Van Criekinge (UGent) , Josef Straub, et al.

(2019) CLINICAL CANCER RESEARCH. 25(6). p.1809-1816
Add to list
- Journal Article
- A1
- open access
Evaluation of an epigenetic assay for predicting repeat prostate biopsy outcome in African American men

Robert L, Jr Waterhouse, Leander Van Neste, Kelvin A Moses, Carlton Barnswell, Jonathan L Silberstein, Mark Jalkut, Ronald Tutrone, James Sylora, Ronald Anglade, Myron Murdock, et al.

(2019) UROLOGY. 128. p.62-65
Add to list
Multicenter optimization and validation of a 2-gene mRNA urine test for detection of clinically significant prostate cancer before initial prostate biopsy

Alexander Haese, Geert Trooskens, Sandra Steyaert, Daphne Hessels, Michael Brawer, Virginie Vlaeminck-Guillem, Alain Ruffion, Derya Tilki, Jack Schalken, Jack Groskopf, et al.

(2019) JOURNAL OF UROLOGY. 202(2). p.256-263
Add to list
- Journal Article
- A1
- open access
Clinically significant prostate cancer diagnosed using a urinary molecular biomarker-based risk score : two case reports

Pieter Minnee, Daphne Hessels, Jack A Schalken and Wim Van Criekinge (UGent)

(2019) BMC UROLOGY. 19(1).
Add to list
PROTEOFORMER 2.0 : further developments in the ribosome profiling-assisted proteogenomic hunt for new proteoforms

Steven Verbruggen (UGent) , Elvis Ndah (UGent) , Wim Van Criekinge (UGent) , Siegfried Gessulat, Bernhard Kuster, Mathias Wilhelm, Gerben Menschaert (UGent) and Petra Van Damme (UGent)

(2019) MOLECULAR & CELLULAR PROTEOMICS. 18(suppl. 1). p.S126-S140
Add to list
- Journal Article
- A1
- open access
MEXPRESS update 2019

Alexander Koch, Jana Jeschke, Wim Van Criekinge (UGent) , Manon van Engeland and Tim De Meyer (UGent)

(2019) NUCLEIC ACIDS RESEARCH. 47(W1). p.W561-W565
Add to list
Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1

Leonel Maldonado, Mariana Brait, Evgeny Izumchenko, Shahnaz Begum, Aditi Chatterjee, Tanusree Sen, Myriam Loyo, Alvaro Barbosa, Maria Luana Poeta, Eugene Makarev, et al.

(2018) CANCER LETTERS. 433. p.242-251
Add to list
Prospective validation of a diagnostic urine test for bladder cancer : the Hematuria study

Kim van Kessel, Joep de Jong, Angelique Ziel-van der Made, Hossain Roshani, Stefan Haensel, Josien van Montfrans-Wolterbeek, Egbert Boeve, Eric Oomens, Niels van Casteren, Joost Boormans, et al.

(2018) JOURNAL OF UROLOGY. 199(4, suppl.). p.e1232-e1232
Add to list
Evaluation of two urinary RNA biomarker tests with an epigenetic DNA assay for the identification of men with high-grade prostate cancer

Geert Trooskens, Anglita Yantisetiasti, Rianne Hendriks, Inge Van Oort, Peter Mulders, Christina Hulsbergen-van de Kaa, Wim Van Criekinge (UGent) and Jack Schalken

(2018) JOURNAL OF UROLOGY. 199(4, suppl.). p.e610-e610

1
2
3
4
…
22
23

Next →